bFGF inhibitors (Genzyme Mol Oncology)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NamebFGF inhibitors (Genzyme Mol Oncology)
Drug Alias NamebFGF inhibitors (GMO)basic FGF inhibitors (Genzyme Molecular Oncology)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor 2 inhibitors
TargetsFibroblast growth factor 2
Therapy Area/IndicationsCoronary RestenosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenzyme Molecular Oncology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenzyme Molecular Oncology
Active IndicationsN/A
Inactive IndicationsCoronary RestenosisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A